Showing results (21-30 of 741) with videos related to
Sort By:
Pageof 75
Research Communications in Chemical Pathology and Pharmacology|August 1, 1978
Metabolism of an amino acid with antidepressant propertiesR L Borison, P J Maple, H S Havdala, et al.Psychopharmacology Bulletin|January 1, 1992
Risperidone: clinical safety and efficacy in schizophreniaR L Borison, A P Pathiraja, B I Diamond, et al.Psychopharmacology Bulletin|January 1, 1990
The use of midazolam in acutely agitated psychiatric patientsM Wyant, B I Diamond, E O'Neal, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 1, 1995
Phenomenology and neurobiology of cocaine withdrawal: are they related?A Pathiraja, D Marazziti, G B Cassano, et al.European Archives of Psychiatry and Clinical Neuroscience|January 1, 1995
A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients. A re-evaluation of the North American risperidone studyH J Möller, H Müller, R L Borison, et al.Psychopharmacology Bulletin|January 1, 1991
A comparative study of alpidem, a nonbenzodiazepine, and lorazepam in patients with nonpsychotic anxietyB I Diamond, H Nguyen, E O'Neal, et al.Psychopharmacology|December 8, 1978
Lithium prevention of amphetamine-induced 'manic' excitement and of reserpine-induced 'depression' in mice: possible role of 2-phenylethylamineR L Borison, H C Sabelli, P J Maple, et al.Annals of Neurology|February 1, 1978
Dopamine binding following prolonged haloperidol pretreatmentA Hitri, W J Weiner, R L Borison, et al.Biological Psychiatry|August 1, 1976
Biochemical plasticity of synaptic transmission: a critical review of Dale's PrincipleH C Sabelli, A D Mosnaim, A J Vazquez, et al.The Analyst|May 14, 1998
Determination of micellar self-diffusion coefficients by micellar electrokinetic chromatographyJ M DavisPageof 75